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(D) binding to Cdc37 as measured by surface plasmon resonance. GSTCDK4 and GSTCDK6 were immobilized on the chip via anti-GST antibody coupling and the Cdc37 ligand was assayed in triplicate over a 5-point serial dilution (4000 nM, 2000 nM, 1000 nM, 250 nM and 62.5 nM). Dissociation constants (CDK4, K d = 347 ± 30 nM; and CDK6, K d = 7000 ± 4500 nM) were derived by using the Biacore S200 Evaluation Software. (E, F) ATP does not displace Cdc37 from CDK4 (E) or CDK6 (F). The ATP was dispensed in a two-fold dilution series starting at 2 mM. DMSO was added at 0.5% (E) or 0.01% (F). The concentrations of GSTCDK4 and GSTCDK6 were 8 nM and 6 nM respectively. T im e ( s )
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Avi-tag beads GSTCDK4 or GSTCDK6 were immobilized on the chip via anti-GST antibody coupling and p16INK4a proteins were flowed over in a 5-point dilution series (200nM, 100 nM, 25 nM, 6.25 nM, and 1.56 nM). K d values were derived using the Biacore S200 Evaluation Software and are presented in Table 2 . 
Supplemental Experimental Procedures
Materials and reagents
Terbium-labelled anti-GST antibody and streptavidin-labelled XL665 dye were purchased from Life Technologies and Cisbio, respectively. CDK4/6 inhibitors PD0332991 (palbociclib) was purchased from Sigma Aldrich, and LY2835219 (abemaciclib) and LEE011 (ribociclib) from MedChem Express, and the Hsp90 ATP-competitive inhibitor NVP-AUY922 was supplied by Santa Cruz Biotechnology. Baculovirus expression for protein production in insect cells Sf9 was performed using the MultiBac™ system (Geneva-Biotech).
Protein expression
Human CDK4 and CDK6 were expressed in Sf9 insect cells using a recombinant baculovirus expression system (Bieniossek et al., 2012) , Geneva-Biotech MultiBac™). Full length human CDK4 and CDK6 with an N-terminal glutathione-S-transferase (GST)-tag and 3C protease recognition site, and human untagged Cdc37 were cloned separately into the pACEBac1 acceptor vector. Human untagged full-length cyclin D1 and cyclin D3 were cloned into the pIDK donor vector. Cre recombinase (New England Biolabs) was used in the Cre-LoxP reaction of acceptor and donor vectors to generate the multigene fusion for co-expression of CDK4 or CDK6 with either cyclin D1 or cyclin D3. All constructs were verified by restriction enzyme digestion and DNA sequencing. Approximately 5-10 ng of DNA vector (either pACE-BAC-1-CDK, pACE-BAC-1-Cdc37 or an acceptor-donor fusion pACE-Bac-1-pIDK for CDK and cyclin D co-expression) was used to transform EmBacY E. coli cells harboring the EMBacY MultiBac™ bacmid (for constitutive expression of yellow fluorescent protein YFP). DNA sequences of interest were transferred to the bacmid via transposition into the mini Tn7 attachment site. White recombinant colonies were selected for subsequent bacmid preparation. MultiBac bacmid DNA was prepared by alkaline lysis (QIAprep Miniprep kit (Qiagen)). The final supernatant was precipitated using isopropanol (40%) and the resulting pellet was then washed twice with 70% ethanol, dried and re-suspended in sterilised water in sterile conditions. For the transfection reaction, transfection reagent (Gene Juice™ (Novagen)) was added to the re-suspended bacmid DNA and the resulting cocktail was used to infect 0.5*10 6
Sf9 cells seeded in 6-well plates. After 48-60 hr incubation at 27 o C, the supernatant was collected and positive transfection was verified by monitoring the appearance of yellow cells constitutively expressing the YFP gene and also containing the constructs of interest by fluorescence microscopy. This initial virus stock (Vo) was amplified twice and then used for protein expression.
Other proteins were expressed from recombinant E. coli cells. Human CDK2 was expressed as a GST fusion from the pGEX6P-1 vector backbone (GE Healthcare) as previously described (Brown et al., 1999) . The full-length DNA sequences encoding herpesvirus saimiri cyclin (Vcyclin) and Kaposi's sarcoma-associated herpesvirus cyclin (Kcyclin) were synthesized (Integrated DNA Technologies). These sequences were sub-cloned into pGEX6P-1 to generate Nterminal GST fusion proteins and also further modified to include either a C-terminal Avi or FLAG tag. Mutant p16INK4a sequences were generated by site-directed mutagenesis using the QuikChange method (Agilent Technologies) or by gene synthesis (Integrated DNA Technologies) and verified by sequencing. The INK sequences were subsequently cloned into a modified pET3d vector to produce a N-terminal His 6 -tagged protein that upon 3C cleavage generates the INK modified by a N-terminal Avi-tag. Full-length p27KIP1, p27KIP1, p21CIP1 and pRb fragments were expressed as GST-fusions from a pGEX6P-1 backbone. For the pull down experiments, full-length Cdc37 was modified with a N-terminal 3C protease-cleavable hexa-histidine tag following cloning into a pRSETA vector backbone. 3C cleavage generates a Cdc37 construct with a FLAG-tag at the N-terminus. For the HTRF experiments, Cdc37 was expressed from a modified pET3d vector to generate C-terminally Avi-tagged proteins. The Hsp90β full length construct was used in this study. This sequence was also expressed with an N-terminal 3C proteasecleavable hexa-histidine tag from a pRSETA vector backbone and for the HTRF assay was expressed from a modified pET3d vector backbone to generate an N-terminally Avi-tagged protein.
Protein purification
Insect cells were harvested after 72 hours of infection, re-suspended in 10 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 0.5 mM EDTA, 0.5 mM TCEP (resuspension buffer) supplemented with a protease inhibitor cocktail (Roche) and stored at -20 o C. Cell pellets were sonicated on ice followed by centrifugation at 48254xg for 1 hr at 4 o C. The filtered supernatant was incubated with 1 ml of glutathione Sepharose (GE Healthcare) for 3 hr on a rocker at 4 o C. The Sepharose resin was then loaded into a column and exhaustively washed with 30 ml of resuspension buffer. Bound proteins were eluted by 20 mM gluthathione at pH 8.0, cleaved overnight with 3C protease (1:50 w/w) and then further purified using size exclusion chromatography (SEC) (HiLoad 16/60 Superdex 75 pg for proteins smaller than ~60 kDa or a 200 pg for proteins or complexes larger than ~60 kDa). To ensure removal of any contaminating GST dimer, appropriate SEC fractions were pooled, incubated with glutathione Sepharose and then concentrated.
Human CDK2, INKs, p21CIP1, p27KIP1, Cdc37, Hsp90β and viral cyclins were expressed in E. coli strain BL21STAR(DE3) (Life Technologies) (CDK2, INKs, p21CIP1, p27KIP1, Cdc37, and viral cyclins) or Rosetta (DE3) (Cdc37 and Hsp90β). Briefly, recombinant E. coli BL21STAR(DE3) cells were grown at 30 o C in 2xYT medium till OD 600~0 .7-0.8, induced at 18 o C by adding 0.5 mM IPTG and further incubated for 16 hr. Alternatively recombinant E. coli Rosetta (DE3) cells (Merck Millipore) expressing Cdc37 or Hsp90β were grown at 37 ο C in LB medium till the OD 600 reached ~0.2 and 0.6 respectively. The cells were then induced at 18 o C by adding 0.5 mM IPTG and incubated for 16 hr. GST-tagged proteins were first purified by an affinity chromatography step, followed by 3C protease cleavage to remove the GST tag and then subsequent SEC. If required, appropriate SEC fractions were pooled and reapplied to a glutathione column to remove any contaminating GST and the flow-through collected. His 6 -tagged proteins were purified using Ni-NTA His-Trap (GE Healthcare), cleaved and further purified using sequential SEC and ion exchange chromatography (HiTrap Q, GE Healthcare). Protein concentrations were determined by NanoDrop2000 UVVis Spectrophotometer (Thermo Scientific) or using a Shimadzu UV1800 spectrophotometer. A representative SDSpolyacrylamide gel stained with silver is shown in Figure S4 to illustrate the purity of the GSTCDK4 and GSTCDK6 post purification.
Protein biotinylation
Avi-tagged proteins (Cdc37, p16INK4a, p16INK4a mutants, Kcyclin and Vcyclin) were biotinylated to provide an affinity tag for the streptavidin-tagged XL665 dye. A substantial amount of biotinylated protein was purified from the recombinant E. coli cells as a result of endogenous BirA activity. Proteins were further modified by incubating 40 µM of the Avi-tagged protein with 10 µg BirA in biotinylation buffer (50 mM Bicine pH 8.3, 10 mM ATP, 10 mM MgOAc, 50 µM d-biotin) at 30°C for 60 minutes. Protein was then buffer exchanged into HTRF buffer A (50 mM HEPES pH 7.5, 100 mM NaCl, 0.1 mg/ml BSA, 1 mM DTT) using a PD-10 desalting column (GE Healthcare). The extent of protein biotinylation was monitored by pull downs using High Capacity NeutrAvidin® Agarose Resin (Thermo Scientific Pierce).
Pull-down assays
For the pull down assays presented in Figure 2C , D, 6.3 µg (0.12 nmol) of FLAG-tagged Cdc37 was incubated for 1 hr at 4 o C with 25 µl anti-FLAG M2 agarose beads in a total volume of 60 µl in 20 mM Tris pH 7.5, 150 mM NaCl, 5 mM Na 2 MoO 4 , 0.5 mM EDTA, 0.5 mM TCEP, and 0.5% Igepal. Using this buffer non-specific protein binding to the beads was minimized. A 3-fold molar excess (0.36 nmol) of the second protein (CDK or CDK-cyclin D was then added and incubation continued for a further hour at 4 o C. Each pull down was washed three times with 200 µl of buffer and then 15 µl of SDS-PAGE sample buffer was added. Boiled and spun down samples were subjected to SDS-PAGE and proteins visualized by InstantBlue staining.
Pull-down assays of chaperone complexes assembled in insect cells
For the pull down assays presented in Figure 2E , F, Figure 3C , D and Figure S2G and H, chaperone complexes containing Hsp90 Sf9-Cdc37-CDK4 or Hsp90 Sf9 -Cdc37-CDK6 were generated by co-expressing human GSTCDK4 or GSTCDK6 with human untagged Cdc37 in Sf9 insect cells using the baculovirus expression system as described above. Complexes were purified using the GST tag on the CDK as described in Vaughan et al. (Vaughan et al., 2006) . Chaperone complexes were separated by SEC (Superdex 200 16/60 (GE Healthcare)). Fractions containing Hsp90 Sf9 -Cdc37-CDK4 or Hsp90 Sf9 -Cdc37-CDK6 were pooled and concentrated. For pull downs, 4.8 µg (0.150 nmol) of biotinylated C-terminally Avi-tagged viral cyclin K (D-type cyclin) or p16INK4a was incubated for 1 hr at 4 o C with 25 µl NeutrAvidin® Agarose Resin in a toal volume of 60 µl (Thermo Scientific Pierce) in 20 mM Tris pH 7.5, 150 mM NaCl, 5 mM Na 2 MoO 4 , 0.5 mM EDTA, 0.5 mM TCEP and 0.5% Igepal. A 3-fold molar excess of chaperone complex purified from insect cells was added and incubated for a further hour at 4 o C. Each pull down was washed as described above and boiled prior to separation by SDS-PAGE. Proteins were visualized by InstantBlue staining.
pRb kinase assay
To assemble the various complexes, 15 µg of Cdc37 was mixed with a molar equivalent of CDK6, and incubated for 1hour at 4 o C. Vcyclin was then added to appropriate samples at a 1:1 molar ratio CDK6:Vcyclin and incubated for a further hour at 4 o C. Vcyclin complexes with Cdc37 or CDK6 were generated by mixing proteins at equivalent 1:1 molar ratios. During incubation steps, the samples were manually mixed half-way through. 200 µl of glutathione bead slurry was washed in pRb assay buffer (50 mM HEPES, pH7.5, 10 mM MgCl 2 , 1 mM DTT, 0.1 mM orthovandate, 1 mM NaF, 0.1 mM EDTA) three times and then 1 mg of GST-pRb encoding pRb residues 379-928 (Kato et al., 1993) was added and incubated for 30 mins at 4 o C. The beads were pelleted, the excess supernatant removed and then resuspended to 200 ul volume. 20 µl of GST-pRb-bead slurry was added to each reaction tube, and the volume made up to 100 µl using pRb assay buffer. The kinase reactions were initiated by the addition of ATP to a final concentration of 2 mM, then allowed to proceed for 30 mins at 30 o C with gentle agitation. The reactions were stopped by addition of 2 x LDS buffer and analysed by SDS-PAGE and subsequent western blotting using an anti-phosphorylated S780 antibody (Abcam, ab173289).
Homogenous time-resolved fluorescence (HTRF) (a) Direct binding format:
In the direct binding assay format glutathione-S-transferase (GST)-tagged cyclin-dependent kinase (CDK) is incubated with biotinylated Avi-tagged protein of interest to form a GSTCDK-protein complex. The complex is then incubated with a Tb-labeled anti-GST antibody and streptavidin-tagged XL665 dye. Formation of a complex brings the Tb and XL665 into proximity so that excitation of the Tb results in emission from the XL665 dye as a result of Förster resonance energy transfer (FRET) between the two probes. To optimize the assay for direct binding measurements the biotinylated protein of interest was initially titrated, over 11 serial dilution points and an additional buffer blank point, against 5 fixed concentrations of either GSTCDK4 or GSTCDK6 (100 nM, 50 nM, 25 nM, 10 nM and 5 nM). Subsequently experiments to assay the various GSTCDK complexes described in Figures 1B; 4C-F; and Figure S2A -D were carried out at a fixed GSTCDK concentration of 10 nM. The concentration of GSTCDK2 and GST used in Figure S1A , B was 25 nM. Concentrations of GSTCDK and the binding protein of interest were prepared in HTRF buffer A (50 mM HEPES, 100 mM NaCl, 1 mM DTT and 0.1 mg/ml BSA) and incubated together for 60 minutes at 4°C or on a shaker at room temperature. 5 nM Tb labeled anti-GST antibody and SAXL665 at 1/8th the concentration of the biotinylated protein, were prepared in HTRF buffer B (50 mM HEPES, 100 mM NaCl and 0.1 mg/ml BSA) and added to each well. The plate was incubated for a further 120 minutes at 4°C, before being scanned. Samples were excited using a wavelength of 337 nm and emission spectra measured at 620 nm and 665 nm (PHERAstar FS (BMG LABTECH)). Binding curves were plotted using GraphPad Prism 6 from which the K d s were determined. The curves shown are representative binding curves from at least two runs with each mutant carried out on separate days.
(b) Competition mode: 8 nM GSTCDK4 and 150 nM C-Avi Cdc37, or 6 nM GSTCDK6 and 500 nM C-Avi Cdc37 (the Cdc37 concentration was adjusted to the measured K d for the CDK-Cdc37 interaction), were added to each well along with a serial dilution of the competitor (viral cyclins, Figure 2A , B; INKs, Figure 3A , B, E, F; CIP/KIPs, Figure 4A , B; ATP competitive inhibitors, Figure 1C , D; or ATP, Figure S1E , F). All dilutions were made using HTRF buffer A (50 mM HEPES, 100 mM NaCl, 1 mM DTT and 0.1 mg/ml BSA) and set up in duplicate. ATP-competitive inhibitor stocks were prepared either in 100% DMSO (LEE011) or water (PD0332991 and LY2835219). LEE011 titrations were carried out at a final DMSO% of 0.1%. The plate was incubated for 60 minutes at 4°C, before 0.5 nM Tb labeled anti-GST antibody and 18.75 nM of SAXL665 (for the CDK4 measurements) or 3 nM Tb labeled anti-GST antibody and 62.5 nM of SAXL665 (for the CDK6 measurements), were added to each well. Concentrations of the Tb antibody and SAXL665 were made up using HTRF buffer B (50 mM HEPES, 100 mM NaCl and 0.1 mg/ml BSA). The plate was incubated for a further 120 minutes at 4°C, before being scanned. Samples were excited using a wavelength of 337 nm and emission spectra measured at 620 nm and 665 nm (PHERAstar FS (BMG LABTECH)). Percentage inhibition graphs were plotted using GraphPad Prism 6, by comparing to a maximum signal, where no competitor is present, and a minimum signal, where no GSTCDK4 or GSTCDK6 is present.
Surface Plasmon Resonance (SPR)
All SPR experiments were performed on a Biacore S200 (GE Healthcare) at 4 °C using SPR buffer (10 mM HEPES pH 7.5, 150 mM NaCl, 3 mM EDTA and 0.05% Tween 20). Samples were centrifuged at 10000 x g for 10 minutes at 4 °C before use. 40 µg/mL GSTCDK4 or 30 µg/mL GSTCDK6 were captured on a surface of goat anti-GST antibody (GE Healthcare) at 5 µL/min for 600s. Antibody capture to the CM5 BIAcore sensor chip was via amine coupling using the standard protocol provided in the GST capture kit (GE Healthcare). Analyte solutions of p16INK4a and p16INK4a mutants at 200 nM, 100 nM, 25 nM, 6.25 nM and 1.56 nM were flowed over the bound GSTCDKs at 30 µL/min for 240s and the dissociation was measured over 600s. Analyte solution of Cdc37 at 4000 nM, 2000 nM, 1000 nM, 250 nM and 62.5 nM were flowed over for 700s and the dissociation measured at 600s. In case of viral cyclins: 500 nM, 250 nM, 62.5 nM, 15.6 nM and 4 nM for 600s and dissociation was measured at 600s. The bound GSTCDKs were removed from the antibody using 10 mM glycine pH 2.1 at 30 µL/min for 240s. The chip was regenerated by capturing fresh GSTCDKs before each analyte concentration run. GST was loaded onto a separate lane at 10 µg/mL for 120s at 5 µL/min to act as a negative control. Sensorgram readings from the GST control were subtracted from GSTCDK sensorgrams to correct for non-specific interactions and bulk effects. K d values and dissociation rates were calculated using the Biacore S200 Evaluation Software.
Differential Scanning Fluorimetry
A protein/Sypro orange mix containing 5 µM protein and a 1:5,000 dilution of dye in DMSO (as supplied by Sigma Aldrich) was prepared just before plate setup in 10 mM HEPES pH 7.5, 150 mM NaCl, 0.5 mM EDTA and 0.5 mM TCEP. 14.5 µL of the protein/Sypro orange mix was aliquoted into 384-well plates and sealed. Each experiment was done in triplicate. Thermal melting experiments were carried out using an QuantStudio Real Time PCR machine (Applied Biosystems). The plates were first equilibrated at 25°C for 2 min in the PCR machine before starting the thermal melting experiment upon which the plates were heated at 0.05°C per second from 25 to 99°C. The fluorescence intensity was recorded using the ROX filters under continuous collection. Raw fluorescence data were extracted from the QuantStudio Real-Time PCR software and analysed using the Applied Biosystems Protein Thermal Shift software. Calculated derivative Tm values for each of the three repeats were extracted and the average values calculated.
Silver staining 3 µg of complexes GST-CDK4 or GST-CDK6 used in HTRF and SPR assays were run on 10% SDS-PAGE gel (Biorad) for 35 minutes in 1xTGS Buffer (Biorad) at 200 V. Subsequently gels were silver stained using Pierce Silver Stain Kit (ThermoScientific) using manufacturer instructions. The gel was stained until bands started appearing and stopped with 5% acetic acid for 10 minutes, followed by 2x 5 minutes washes with ultrapure water.
Western blotting SfHsp90-Cdc37-CDK4 purified from insect cells (10 µg) was incubated with buffer or p16INK4a (20 µg) for 60 minutes on ice and immuno-precipitated with anti-Hsp90 antibodies (abcam AC88 #ab13492) overnight. Bead bound proteins were washed 3x times with Lysis/Wash buffer (ThermoFisher Scientific, #26146). Subsequent to SDS-PAGE samples were western blotted using anti -Hsp90 (Cell Signaling, #4874), -Cdc37 (ThermoFisher Scientific, C1 #MA3-029), -CDK4 (Cell signaling, CDK4 (D9G3E) #12790) and -p16INK4a (Abcam, DCS50.1, #ab16123) antibodies.
